These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38512513)

  • 1. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
    Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
    Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
    J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
    Meng X; Fang E; Zhao X; Feng J
    Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
    Meng X; Li H; Fang E; Feng J; Zhao X
    Front Oncol; 2020; 10():1411. PubMed ID: 32974147
    [No Abstract]   [Full Text] [Related]  

  • 7. Machine learning methods revealed the roles of immune-metabolism related genes in immune infiltration, stemness, and prognosis of neuroblastoma.
    Mu J; Gong J; Lin P; Zhang M; Wu K
    Cancer Biomark; 2023; 38(2):241-259. PubMed ID: 37545226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
    Meng X; Feng C; Fang E; Feng J; Zhao X
    J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation.
    Wang Y; Xu Y; Liu C; Yuan C; Zhang Y
    Front Immunol; 2023; 14():1233260. PubMed ID: 37799714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients.
    Cangelosi D; Blengio F; Versteeg R; Eggert A; Garaventa A; Gambini C; Conte M; Eva A; Muselli M; Varesio L
    BMC Bioinformatics; 2013; 14 Suppl 7(Suppl 7):S12. PubMed ID: 23815266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune-related signature with prognosis in children with stage 4 and 4S neuroblastoma.
    Cao L; Liu Q; Ma Y; Wang S
    Clin Transl Oncol; 2024 Apr; 26(4):905-916. PubMed ID: 37709978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.
    Jin W; Zhang Y; Zhao Z; Gao M
    Theranostics; 2024; 14(9):3439-3469. PubMed ID: 38948053
    [No Abstract]   [Full Text] [Related]  

  • 14. Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait.
    Decock A; Ongenaert M; De Wilde B; Brichard B; Noguera R; Speleman F; Vandesompele J
    Epigenetics; 2016 Oct; 11(10):761-771. PubMed ID: 27599161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response.
    Yang J; Han L; Sha Y; Jin Y; Li Z; Gong B; Li J; Liu Y; Wang Y; Zhao Q
    Front Immunol; 2022; 13():1061814. PubMed ID: 36605200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
    Cangelosi D; Muselli M; Parodi S; Blengio F; Becherini P; Versteeg R; Conte M; Varesio L
    BMC Bioinformatics; 2014; 15 Suppl 5(Suppl 5):S4. PubMed ID: 25078098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma.
    Song J; Song L; Lv Z; Liu J; Feng X; Zhang S; Song A
    Int J Genomics; 2022; 2022():2417351. PubMed ID: 35535346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
    Yang H; Yang J; Bian H; Wang X
    Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitochondria-related genes associated neuroblastoma signature - based on bulk and single-cell transcriptome sequencing data analysis, and experimental validation.
    Wang C; Tan J; Jin Y; Li Z; Yang J; Jia Y; Xia Y; Gong B; Dong Q; Zhao Q
    Front Immunol; 2024; 15():1415736. PubMed ID: 38962012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
    Bénard J; Raguénez G; Kauffmann A; Valent A; Ripoche H; Joulin V; Job B; Danglot G; Cantais S; Robert T; Terrier-Lacombe MJ; Chassevent A; Koscielny S; Fischer M; Berthold F; Lipinski M; Tursz T; Dessen P; Lazar V; Valteau-Couanet D
    Mol Oncol; 2008 Oct; 2(3):261-71. PubMed ID: 19383347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.